(Q34627169)

3 August 2017

title

Residual symptoms in depressed outpatients who respond by 50% but do not remit to antidepressant medication (English)

1 reference

3 August 2017

author

Stephen R. Wisniewski

object named as

Stephen R Wisniewski

3

0 references

Augustus John Rush

object named as

Augustus John Rush

10

0 references

Madhukar Trivedi

6

object named as

Madhukar H Trivedi

1 reference

3 August 2017

9

Diane Warden

1 reference

3 August 2017

4

Andrew A Nierenberg

1 reference

3 August 2017

1

Shawn M McClintock

1 reference

3 August 2017

Mustafa M Husain

2

1 reference

3 August 2017

Jonathan W Stewart

5

1 reference

3 August 2017

Ian Cook

7

1 reference

3 August 2017

David Morris

8

1 reference

3 August 2017

language of work or name

English

0 references

publication date

1 April 2011

1 reference

Journal of Clinical Psychopharmacology

3 August 2017

published in

1 reference

3 August 2017

volume

31

1 reference

3 August 2017

issue

2

1 reference

3 August 2017

page(s)

180-186

1 reference

Relationship of residual mood and panic-agoraphobic spectrum phenomenology to quality of life and functional impairment in patients with major depression.

3 August 2017

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3677201

Sleep disturbances: core symptoms of major depressive disorder rather than associated or comorbid disorders

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3677201

Which depressive symptoms remain after response to cognitive therapy of depression and predict relapse and recurrence?

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3677201

Strategies to enhance the therapeutic efficacy of antidepressants: targeting residual symptoms

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3677201

A double blind, placebo-controlled pilot study of galantamine augmentation of antidepressant treatment in older adults with major depression

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3677201

Disability in major depression related to self-rated and objectively-measured cognitive deficits: a preliminary study

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3677201

Residual symptoms and recurrence during maintenance treatment of late-life depression

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3677201

Antidepressants and the risk of suicide, attempted suicide, and overall mortality in a nationwide cohort

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3677201

Pharmacological approaches to the treatment of residual symptoms

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3677201

Evaluation of outcomes with citalopram for depression using measurement-based care in STAR*D: implications for clinical practice

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3677201

Sequenced treatment alternatives to relieve depression (STAR*D): rationale and design

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3677201

A rating scale for depression

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3677201

Remission and recurrence of depression in the maintenance era: long-term outcome in a Cambridge cohort

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3677201

Background and rationale for the sequenced treatment alternatives to relieve depression (STAR*D) study.

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3677201

The Psychiatric Diagnostic Screening Questionnaire: development, reliability and validity

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3677201

The reliability and validity of a screening Questionnaire for 13 DSM-IV Axis I disorders (the Psychiatric Diagnostic Screening Questionnaire) in psychiatric outpatients.

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3677201

Residual symptoms in depressed patients who respond acutely to fluoxetine.

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3677201

The increased use of antidepressants has contributed to the worldwide reduction in suicide rates

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3677201

Relationship between residual symptoms of depression and self-reported cognitive impairment

26 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3677201

Residual symptoms after remission of major depressive disorder with citalopram and risk of relapse: a STAR*D report.

26 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3677201

Effects of selective serotonin reuptake and dual serotonergic-noradrenergic reuptake treatments on memory and mental processing speed in patients with major depressive disorder

26 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3677201

Depression, chronic diseases, and decrements in health: results from the World Health Surveys.

26 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3677201

A comparison of rates of residual insomnia symptoms following pharmacotherapy or cognitive-behavioral therapy for major depressive disorder.

26 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3677201

A cross-sectional study of the prevalence of cognitive and physical symptoms during long-term antidepressant treatment.

26 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3677201

Comorbid psychiatric disorders in depressed outpatients: demographic and clinical features.

26 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3677201

Residual symptoms at remission from depression: impact on long-term outcome.

26 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3677201

Effects of adding cognitive therapy to fluoxetine dose increase on risk of relapse and residual depressive symptoms in continuation treatment of major depressive disorder

26 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3677201

Self-rated residual symptoms do not predict 1-year recurrence of depression

26 October 2018

1 reference

12 December 2020

Relapse of major depression after complete and partial remission during a 2-year follow-up

1 reference

12 December 2020

Prevention of relapse in residual depression by cognitive therapy: a controlled trial

1 reference

12 December 2020

The 16-Item quick inventory of depressive symptomatology (QIDS), clinician rating (QIDS-C), and self-report (QIDS-SR): a psychometric evaluation in patients with chronic major depression

1 reference

12 December 2020

Residual symptoms after partial remission: an important outcome in depression

1 reference

12 December 2020

Self-reported sleep disturbance as a prodromal symptom in recurrent depression

1 reference

12 December 2020

Remission and residual symptomatology in major depression

1 reference

12 December 2020

Computerized assessment of depression and anxiety over the telephone using interactive voice response

1 reference

12 December 2020

Neurocognitive deficits and disability in major depressive disorder

1 reference

12 December 2020

STAR*D: what have we learned?

1 reference

12 December 2020

The concept of recovery in major depression

1 reference

12 December 2020

10.1097/JCP.0B013E31820EBD2C

Identifiers

DOI

1 reference

3 August 2017

1 reference

3 August 2017

1 reference